Natalizumab
Products in Health Canada’s databases that list Natalizumab as a medicinal or active ingredient, under this spelling. The same substance can be listed under another name (a salt, a common name), which has its own page.
- Drug products
- 2
- 2 authorized now
- Natural health products
- 0
- 0 active licences
- Notices of Compliance
- 11
- Products in all
- 2
Drug products
Authorized products first.
| Name | DIN | Status | Holder | Status since |
|---|---|---|---|---|
| TYSABRI (300 MG) | 02286386 | Marketed | Biogen Canada Inc | |
| TYRUKO (300 MG) | 02561123 | Approved | Polpharma Biologics S.A. |
Notices of Compliance
Approvals of drug submissions that list it, newest first.
- TYSABRIOctober 6, 2026 · NOC 38418
- TYRUKOSeptember 24, 2025 · NOC 36056
- TYSABRIJanuary 9, 2025 · NOC 34664
- TYSABRISeptember 13, 2024 · NOC 34015
- TYSABRIAugust 21, 2023 · NOC 31461
- TYSABRIApril 10, 2014 · NOC 15502
- TYSABRIApril 25, 2012 · NOC 15559
- TYSABRISeptember 17, 2009 · NOC 10603
- TYSABRIOctober 17, 2008 · NOC 9839
- TYSABRIJuly 17, 2007 · NOC 8909
- TYSABRISeptember 28, 2006 · NOC 8282